Drugs / IVOSPEMIN
IVOSPEMIN
also known as
SUN-101 · SBP-101 · IVOSPEMIN HYDROCHLORIDE · Ivospemin tetrahydrochloride · Longhala Magnair · SBP-101 TETRAHYDROCHLORIDE
Trials 7 · a red edge is where a trial was stopped
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IVOSPEMIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | IVOSPEMIN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | Ivospemin tetrahydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | Longhala Magnair | “Longhala™ Magnair™ (glycopyrrolate) Inhalation Solution, a drug/device combination of the long-acting antimuscarinic glycopyrrolate administered using the eFlow® closed system...” PMID 30584583 ↗ Jun 2018 |
| Known as | SBP-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02657330 ↗ |
| Known as | SBP-101 TETRAHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | SUN-101 | “SUN-101 3 mcg bid” NCT02038829 ↗ |
| Modality | Other / unclassified | “a drug/device combination of the long-acting antimuscarinic glycopyrrolate administered using the eFlow® closed system (eFlow CS) nebulizer” PMID 30584583 ↗ Jun 2018 |
| Route | Inhaled | “via eFlow Closed System (CS) nebulizer” NCT02276222 ↗ |